AR097216A1 - Composición para el tratamiento contra el envejecimiento de la piel - Google Patents
Composición para el tratamiento contra el envejecimiento de la pielInfo
- Publication number
- AR097216A1 AR097216A1 ARP140102923A ARP140102923A AR097216A1 AR 097216 A1 AR097216 A1 AR 097216A1 AR P140102923 A ARP140102923 A AR P140102923A AR P140102923 A ARP140102923 A AR P140102923A AR 097216 A1 AR097216 A1 AR 097216A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- hyaluronate
- extract
- alkanol
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 9
- 230000009759 skin aging Effects 0.000 title 1
- 229940014041 hyaluronate Drugs 0.000 abstract 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 3
- -1 ascorbyl hyaluronate Chemical compound 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 3
- 229920002674 hyaluronan Polymers 0.000 abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 244000025221 Humulus lupulus Species 0.000 abstract 2
- 235000008694 Humulus lupulus Nutrition 0.000 abstract 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente está dirigida a una composición que comprende un extracto de Humulus lupulus combinado con ácido hialurónico y un alcanol C₁₋₄, y a su uso como un tratamiento contra el envejecimiento para la piel del ser humano. Para el uso de la presente, la composición se administra tópicamente. Reivindicación 1: Una composición que contiene: a) un extracto de Humulus lupulus, b) ácido hialurónico o una sal o éster farmacéuticamente aceptable del mismo, c) alcanol C₁₋₄, en donde el ácido hialurónico o una sal o éster farmacéuticamente aceptable del mismo se encuentra presente en concentración w/w desde 0.04% a 2.0%, y en donde el alcanol C₁₋₄ se encuentra presente en una concentración w/w desde 0.5% a 15%. Reivindicación 2: La composición de acuerdo con la reivindicación 1, caracterizada porque dicho extracto es un extracto líquido, semi-líquido o sólido. Reivindicación 4: La composición de acuerdo con la reivindicación 3, caracterizada porque la cantidad de dicho extracto es desde 0.1 a 15% por peso de la composición total, preferentemente desde 0.2 a 5%. Reivindicación 7: La composición de acuerdo con la reivindicación 1, caracterizada porque dicho éster farmacéuticamente aceptable es seleccionado de hialuronato de ascorbilo, hialuronato de palmitoilo, hialuronato de bencilo, hialuronato de de butirilo de sodio, hialuronato de butirilo / formoilo. Reivindicación 8: La composición de acuerdo con la reivindicación 1, caracterizada porque el alcanol C₁₋₄ es etanol.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13179245.9A EP2835130A1 (en) | 2013-08-05 | 2013-08-05 | Composition for skin anti-ageing treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR097216A1 true AR097216A1 (es) | 2016-02-24 |
Family
ID=48906184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102923A AR097216A1 (es) | 2013-08-05 | 2014-08-04 | Composición para el tratamiento contra el envejecimiento de la piel |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20160175241A1 (es) |
| EP (2) | EP2835130A1 (es) |
| JP (1) | JP2016527292A (es) |
| CN (1) | CN105555250A (es) |
| AR (1) | AR097216A1 (es) |
| AU (1) | AU2014304620A1 (es) |
| BR (1) | BR112016002580A2 (es) |
| CA (1) | CA2919771A1 (es) |
| HK (1) | HK1220138A1 (es) |
| IL (1) | IL243759A0 (es) |
| MX (1) | MX2016001686A (es) |
| TW (1) | TW201536343A (es) |
| UY (1) | UY35695A (es) |
| WO (2) | WO2015018792A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6647832B2 (ja) * | 2015-03-13 | 2020-02-14 | サントリーホールディングス株式会社 | ノンアルコールのビールテイスト飲料 |
| US9993578B1 (en) * | 2017-01-12 | 2018-06-12 | Lorstan Pharmaceutical, LLC | Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth |
| CN113082289A (zh) * | 2018-08-27 | 2021-07-09 | 白晋 | 一种包含自体胶原蛋白的复合制剂及其应用 |
| CN110467689A (zh) * | 2019-09-09 | 2019-11-19 | 山东众山生物科技有限公司 | 一种透明质酸衍生物及其制备方法 |
| WO2025219934A1 (en) * | 2024-04-18 | 2025-10-23 | The Wave Innovation Group S.R.L. | Composition based on hyaluronic acid, epigallocatechin-3-o- gallate and/or xanthohumol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3045590B2 (ja) * | 1991-12-24 | 2000-05-29 | 鐘紡株式会社 | 養毛化粧料 |
| RU2078561C1 (ru) * | 1994-04-28 | 1997-05-10 | Стекольников Леонид Ильич | Косметическое средство, предотвращающее старение кожи |
| JP3634112B2 (ja) * | 1997-03-31 | 2005-03-30 | 株式会社資生堂 | 皮膚外用剤 |
| JP3504590B2 (ja) * | 2000-06-28 | 2004-03-08 | 株式会社ノエビア | 皮膚外用剤 |
| US20030039747A1 (en) * | 2001-08-27 | 2003-02-27 | Optinel Systems,Inc. | Method of enhancing waveguide photosensitivity and waveguide having enhanced photosensitivity |
| JP2003261435A (ja) * | 2002-03-11 | 2003-09-16 | Ichimaru Pharcos Co Ltd | エネルギー変性剤 |
| JP2004035440A (ja) * | 2002-07-02 | 2004-02-05 | Ichimaru Pharcos Co Ltd | くすみ抑制剤及び肌質改善用皮膚外用剤 |
| ITMI20060122A1 (it) | 2006-01-25 | 2007-07-26 | Polichem Sa | Composizioni per uso vaginale |
| JP2008050311A (ja) * | 2006-08-25 | 2008-03-06 | Kowa Co | 使用感の良い乳化組成物 |
| DE102008014289A1 (de) * | 2008-03-11 | 2009-09-17 | Coty Prestige Lancaster Group Gmbh | Kosmetikum mit Anti-Alterungswirkung |
| KR20140129081A (ko) * | 2012-02-15 | 2014-11-06 | Jfe 죠코 가부시키가이샤 | 연질화용 강 및 이 강을 소재로 하는 연질화 부품 |
-
2013
- 2013-08-05 EP EP13179245.9A patent/EP2835130A1/en not_active Withdrawn
-
2014
- 2014-08-01 TW TW103126323A patent/TW201536343A/zh unknown
- 2014-08-04 AU AU2014304620A patent/AU2014304620A1/en not_active Abandoned
- 2014-08-04 AR ARP140102923A patent/AR097216A1/es unknown
- 2014-08-04 US US14/910,098 patent/US20160175241A1/en not_active Abandoned
- 2014-08-04 HK HK16108275.1A patent/HK1220138A1/zh unknown
- 2014-08-04 BR BR112016002580A patent/BR112016002580A2/pt not_active Application Discontinuation
- 2014-08-04 WO PCT/EP2014/066723 patent/WO2015018792A1/en not_active Ceased
- 2014-08-04 CA CA2919771A patent/CA2919771A1/en not_active Abandoned
- 2014-08-04 JP JP2016532347A patent/JP2016527292A/ja active Pending
- 2014-08-04 EP EP14747043.9A patent/EP3030219A1/en not_active Withdrawn
- 2014-08-04 WO PCT/EP2014/066722 patent/WO2015018791A1/en not_active Ceased
- 2014-08-04 CN CN201480042643.0A patent/CN105555250A/zh active Pending
- 2014-08-04 MX MX2016001686A patent/MX2016001686A/es unknown
- 2014-08-05 UY UY0001035695A patent/UY35695A/es not_active Application Discontinuation
-
2016
- 2016-01-24 IL IL243759A patent/IL243759A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3030219A1 (en) | 2016-06-15 |
| HK1220138A1 (zh) | 2017-04-28 |
| CN105555250A (zh) | 2016-05-04 |
| IL243759A0 (en) | 2016-04-21 |
| CA2919771A1 (en) | 2015-02-12 |
| TW201536343A (zh) | 2015-10-01 |
| BR112016002580A2 (pt) | 2017-08-01 |
| WO2015018791A1 (en) | 2015-02-12 |
| AU2014304620A1 (en) | 2016-02-25 |
| EP2835130A1 (en) | 2015-02-11 |
| UY35695A (es) | 2014-10-31 |
| WO2015018792A1 (en) | 2015-02-12 |
| JP2016527292A (ja) | 2016-09-08 |
| US20160175241A1 (en) | 2016-06-23 |
| MX2016001686A (es) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020001083A (es) | Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial. | |
| CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
| MX394291B (es) | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. | |
| AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
| BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
| BR112014010275A2 (pt) | formulações para tratamento de diabetes | |
| AR097216A1 (es) | Composición para el tratamiento contra el envejecimiento de la piel | |
| MX366773B (es) | Composicion topica para lavado para su uso en pacientes con acne. | |
| CL2011002634A1 (es) | Disolucion acuosa sin alcohol etilico que comprende propanolol o una sal farmaceuticamente aceptable del mismo, un edulcorante tipo no azucarado y menos del 0,01 % (p/v) de un agente conservante; procedimiento de preparacion; uso de la disolucion en el tratamiento de hemangiomas. | |
| BR112015001313A2 (pt) | composições de vacina | |
| BR112014005398A2 (pt) | peptídeo que inibe a atividade de metaloproteinases de matriz e uso do mesmo | |
| CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
| EA201690854A1 (ru) | Фармацевтические композиции с гидратирующим и смазывающим действием | |
| MX2018006409A (es) | Articulo que contiene celulosa, biotecnologicamente producida, para uso dermatologico. | |
| MX2015003074A (es) | Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. | |
| PE20130237A1 (es) | Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea | |
| MX395112B (es) | Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial. | |
| AR084197A1 (es) | Composicion para uso topico para el tratamiento de trastornos de la piel | |
| BR112014029874A8 (pt) | composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica | |
| PH12015501739B1 (en) | Topical antifungal composition for treating onychomycosis | |
| BR112015014261A8 (pt) | composto de danazol, seu uso e formulação farmacêutica compreendendo este | |
| MX2015012716A (es) | Composiciones para el uso en el tratamiento de trastornos oculares que usan dipiridamol. | |
| PE20142375A1 (es) | Composiciones farmaceuticas topicas que comprenden bexaroteno y corticosteroides | |
| EA201590638A1 (ru) | Композиция, содержащая экстракт галобактерий, для местного применения, предназначенная для лечения лучевого повреждения ткани кожи | |
| EA201200754A1 (ru) | Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |